the Board appointed Mark Kent, currently serving as the Company’s Interim Chief Executive Officer, as its permanent Chief Executive Officer, thereby removing the interim designation.
Departed
Dr. Marlow Hernandez
Director
Cano Health, Inc.
Effective
2023-08-19
Filed
August 21, 2023, 7:59 PM ET
accepted Dr. Marlow Hernandez’ resignation from the Company’s Board, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 1.0
Mark Kent was elected as Director at Cano Health, Inc..
Mark Kent was appointed as Chief Executive Officer at Cano Health, Inc..
Action
appointed
Role
Chief Executive Officer
Exact text from the filing
the Board appointed Mark Kent, currently serving as the Company’s Interim Chief Executive Officer, as its permanent Chief Executive Officer, thereby removing the interim designation.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.